FRANKLIN STEPHEN F the founder of Evgen Pharma, has over 20 years’ commercial experience in life science industries, focusing on the commercialisation of new technology. He was the founder of Provexis plc, a nutraceutical company, and was its chief executive at the time of its admission to AIM in 2005. Prior to that, Stephen was a principal executive with ANGLE plc, the AIM quoted technology commercialisation company, having previously held a business development role with Manchester Biotech (now University of Manchester Innovation Company), one of the largest campus-based incubators in Europe; in these roles he helped establish a portfolio of drug discovery and development businesses. Stephen has a BSc in Biology (York), a PhD in Applied Biochemistry (Nottingham) and an MBA with distinction (Nottingham). He is a Fellow of the Royal Society of Medicine and an alumni of the Royal Commission for the Exhibition of 1851.
Drug delivery